<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03864276</url>
  </required_header>
  <id_info>
    <org_study_id>4-2018-1164</org_study_id>
    <nct_id>NCT03864276</nct_id>
  </id_info>
  <brief_title>The Comparison of Changes of QTc, Tp-e Interval, and Tp-e/QT Ratio, Tp-e/QTc Ratio on the ECG During Living Donor Liver Transplantation Under Desflurane and Total Intravenous Anesthesia -Randomized Controlled Trial</brief_title>
  <official_title>The Comparison of Changes of QTc, Tp-e Interval, and Tp-e/QT Ratio, Tp-e/QTc Ratio on the ECG During Living Donor Liver Transplantation Under Desflurane and Total Intravenous Anesthesia -Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prolonged corrected QT interval (QTc) has been observed in about half of patients with liver
      cirrhosis. Marked prolongation of QTc (ie, 500 msec) has been considered to be a risk factor
      for fatal ventricular arrhythmia, such as torsade de pointes,7,8 which has been reported in
      liver transplantation (LT) surgery. In a previous study, prolonged QTc interval ( 500 msec)
      was frequently observed throughout the procedure of LT, even among patients with baseline QTc
      440 msec. Therefore, it is important to optimize electrolyte balance and hemodynamic status
      to reduce greater risk of perioperative arrhythmias.

      The investigators hypothesized that the change of QTc interval might be differ according to
      method of general anesthesia (inhalation agent vs. intravenous agent).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">April 2019</start_date>
  <completion_date type="Anticipated">November 2020</completion_date>
  <primary_completion_date type="Anticipated">October 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Arm 1: inhalation anesthesia (desflurane) group Arm 2: total intravenous anesthesia (propofol) group</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>patients will be randomly allocated to 2 groups using computer-generated randomization method. Care provider will not be blinded to the group allocation, because anesthesiologists should be aware of the method of anesthesia.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>QTc interval</measure>
    <time_frame>3 minutes after liver reperfusion</time_frame>
    <description>The investigator will assess the QTc interval 3 minutes after the reperfusion during liver transplantation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>QTc interval</measure>
    <time_frame>at the end of the surgery</time_frame>
    <description>The investigator will assess the QTc interval at the end of liver transplantation.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Liver Cirrhosis(Who Will Undergo Planed Liver Transplantation)</condition>
  <arm_group>
    <arm_group_label>inhalation anesthesia (desflurane) group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Anesthesia is induced and maintained with desflurane and sufentanil</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Total intravenous anesthesia (propofol) group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Anesthesia is induced and maintained with propofol and sufentanil</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>inhalation (desflurane) group</intervention_name>
    <description>Anesthesia is induced and maintained with desflurane and sufentanil</description>
    <arm_group_label>inhalation anesthesia (desflurane) group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>total intravenous (propofol) anesthesia</intervention_name>
    <description>Anesthesia is induced and maintained with propofol and sufentanil</description>
    <arm_group_label>Total intravenous anesthesia (propofol) group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with liver cirrhosis who will undergo planned liver transplantation

        Exclusion Criteria:

          -  1. emergent liver transplantation

          -  2. unstable angina

          -  3. recent MI(Myocardial Infarction)

          -  4. uncontrolled hypertension (diastolic BP &gt; 110mmHg)

          -  5. implantable cardiac defibrillator

          -  6. severe obesity (BMI&gt;30kg/m2)

          -  7. allergy to propofol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bon-Nyeo Koo, Ph.D.</last_name>
      <phone>82-2-2228-2420</phone>
      <email>koobn@yuhs.ac</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 4, 2019</study_first_submitted>
  <study_first_submitted_qc>March 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 6, 2019</study_first_posted>
  <last_update_submitted>March 8, 2019</last_update_submitted>
  <last_update_submitted_qc>March 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 11, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Cirrhosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Desflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>Data will become available when the script for this study is accepted in journal.</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

